Compounds > s-nitrosoglutathione
Page last updated: 2024-08-26

s-nitrosoglutathione and glucosamine

s-nitrosoglutathione has been researched along with glucosamine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butler, AR; Mazzei, FA; Megson, IL; Miller, MR; Roseberry, MJ; Webb, DJ2
Campanella, C; Megson, IL; Sogo, N; Webb, DJ1
Butler, AR; Mazzei, FA; Megson, IL; Sogo, N; Walton, JC; Webb, DJ1
Magid, KS; Megson, IL; Shaw, CA; Sogo, N; Webb, DJ1

Other Studies

5 other study(ies) available for s-nitrosoglutathione and glucosamine

ArticleYear
Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteries.
    European journal of pharmacology, 2000, Sep-01, Volume: 403, Issue:1-2

    Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; Femoral Artery; Glucosamine; Glutathione; Hemoglobins; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroglycerin; Nitroso Compounds; Oxadiazoles; Penicillamine; Perfusion; Phenylephrine; Quinoxalines; Rats; Rats, Wistar; S-Nitrosoglutathione; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents

2000
S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
    British journal of pharmacology, 2000, Volume: 131, Issue:6

    Topics: Acetylcholine; Coronary Artery Bypass; Coronary Disease; Enzyme Inhibitors; Glucosamine; Glutathione; Humans; Mammary Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroso Compounds; Penicillamine; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; Saphenous Vein; Vasodilation; Vasodilator Agents

2000
Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
    British journal of pharmacology, 2000, Volume: 131, Issue:7

    Topics: Adult; Cyclic GMP; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Erythrocytes; Fibrinolytic Agents; Glucosamine; Glutathione; Hemoglobins; Humans; Male; Mercaptoethanol; Nitric Oxide; Nitroso Compounds; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; S-Nitrosothiols

2000
Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries.
    European journal of pharmacology, 2000, Nov-24, Volume: 408, Issue:3

    Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; Femoral Artery; Glucosamine; Glutathione; Guanylate Cyclase; In Vitro Techniques; Male; Methemoglobin; Nitric Oxide Donors; Nitroglycerin; Nitroso Compounds; Oxadiazoles; Penicillamine; Phenylephrine; Quinoxalines; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Vasoconstrictor Agents; Vasodilation

2000
Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Biochemical and biophysical research communications, 2000, Dec-20, Volume: 279, Issue:2

    Topics: Adenosine Diphosphate; Adult; Blood Platelets; Collagen; Cyclic GMP; Enzyme Inhibitors; Glucosamine; Glutathione; Humans; In Vitro Techniques; Kinetics; Models, Biological; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Nitroso Compounds; Oxadiazoles; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; Quaternary Ammonium Compounds; Quinoxalines; S-Nitrosoglutathione

2000